1. Home
  2. LPCN vs MOGU Comparison

LPCN vs MOGU Comparison

Compare LPCN & MOGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • MOGU
  • Stock Information
  • Founded
  • LPCN 1997
  • MOGU 2011
  • Country
  • LPCN United States
  • MOGU China
  • Employees
  • LPCN N/A
  • MOGU N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • MOGU Business Services
  • Sector
  • LPCN Health Care
  • MOGU Consumer Discretionary
  • Exchange
  • LPCN Nasdaq
  • MOGU Nasdaq
  • Market Cap
  • LPCN 16.1M
  • MOGU 17.8M
  • IPO Year
  • LPCN N/A
  • MOGU 2018
  • Fundamental
  • Price
  • LPCN $2.95
  • MOGU $2.39
  • Analyst Decision
  • LPCN Strong Buy
  • MOGU
  • Analyst Count
  • LPCN 2
  • MOGU 0
  • Target Price
  • LPCN $9.00
  • MOGU N/A
  • AVG Volume (30 Days)
  • LPCN 36.3K
  • MOGU 6.8K
  • Earning Date
  • LPCN 08-05-2025
  • MOGU 08-19-2025
  • Dividend Yield
  • LPCN N/A
  • MOGU N/A
  • EPS Growth
  • LPCN N/A
  • MOGU N/A
  • EPS
  • LPCN N/A
  • MOGU N/A
  • Revenue
  • LPCN $4,208,119.00
  • MOGU $19,462,964.00
  • Revenue This Year
  • LPCN N/A
  • MOGU N/A
  • Revenue Next Year
  • LPCN N/A
  • MOGU N/A
  • P/E Ratio
  • LPCN N/A
  • MOGU N/A
  • Revenue Growth
  • LPCN N/A
  • MOGU N/A
  • 52 Week Low
  • LPCN $2.68
  • MOGU $1.81
  • 52 Week High
  • LPCN $6.17
  • MOGU $3.14
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 37.54
  • MOGU 57.05
  • Support Level
  • LPCN $2.92
  • MOGU $2.15
  • Resistance Level
  • LPCN $3.25
  • MOGU $2.41
  • Average True Range (ATR)
  • LPCN 0.19
  • MOGU 0.15
  • MACD
  • LPCN -0.04
  • MOGU 0.00
  • Stochastic Oscillator
  • LPCN 4.41
  • MOGU 67.29

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company, that is engaged in research and development for the delivery of drugs using its proprietary delivery technology. Its principal operation is to provide oral delivery solutions for existing drugs. Lipocine develops its drug candidates or it develops drug candidates on behalf of or in collaboration with corporate partners. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, TLANDO, TLANDO XR, LPCN 1148, LPCN 1107, LPCN 1154, and LIP'RAL7 Technology. The Company has a single reportable segment, research, and development for the delivery of drugs using its proprietary delivery technology.

About MOGU MOGU Inc. (each representing 25)

MOGU Inc is an online fashion and lifestyle destination in China. The company's online platform includes Mogu.com, Mogujie.com, and Meilishuo.com. Its platform allows people to discover and share fashion trends while fully enjoying the shopping experience. The company on its platform provides content related to fashion and lifestyle guides in various multi-media formats which include Live Video Broadcasts, Short-form Videos, Photography, and Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology and other relevant services to merchants and users as well as technology services to brands owners.

Share on Social Networks: